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EDITORIAL
In time:  the persistence  of congenital  syphilis  in Brazil
-- More progress  needed!
Em  tempo:  a  persistência  da  síﬁlis  congênita  no  Brasil  --  Mais  avanc¸os são
necessários!
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BDespite  decades  of  epidemiologic  and  clinical  experience
with  maternal  and  congenital  syphilis,  both  remain  major
public  health  problems  in  Brazil  and  in  the  rest  of  the
Americas.  In  2010  and  supported  by  the  World  Health  Organi-
zation  (WHO),  the  Pan  American  Health  Organization  (PAHO)
Member  States  approved  the  Strategy  and  Plan  of  Action
for  the  Elimination  of  Mother-to-Child  Transmission  of  HIV
and  Congenital  Syphilis  with  the  goal  of  reducing  the  inci-
dence  of  congenital  syphilis  to  ≤0.5  cases  per  1000  live
births  by  2015.1 In  2014,  17,400  cases  (1.3/1000  live  births)
of  congenital  syphilis  were  reported  in  the  Americas,  and
17  countries  may  have  eliminated  maternal-to-child  trans-
mission  of  syphilis.2 Despite  some  progress,  Brazil  did  not
meet  the  congenital  syphilis  elimination  goal  but  rather,  the
epidemic  rages  on,  resulting  in  substantial  fetal  and  neona-
tal  mortality.  In  2010,  6916  cases  (2.27/1000  live  births)
of  congenital  syphilis  were  reported  to  the  Brazilian  Min-
istry  of  Health  and  PAHO,  while  in  2013,  the  number  of
cases  increased  to  13,705  (4.70/1000  live  births)  before
decreasing  to  6793  cases  in  2014.2,3
Congenital  syphilis  is  a  preventable  disease,  and  there
must  be  zero  tolerance  for  its  occurrence  as  even  one
case  represents  a  failure  of  the  public  health  system.
Health  care  professionals  know  what  must  be  done  to
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license (http://creativecommons.org/licenses/by/4.0/).revent  congenital  syphilis  and  its  complications  which
nclude  stillbirth,  prematurity,  nonimmune  hydrops  fetalis,
nd  neonatal  mortality.4 The  WHO  estimates  that  glob-
lly,  1.5--1.85  million  pregnant  women  are  infected  with
yphilis  annually  and  half  of  them  have  infants  with  adverse
utcomes.4 In  the  United  States  from  1999  to  2013,  neonatal
ortality  secondary  to  congenital  syphilis  was  12/1000  live
irths,  with  a  case  fatality  rate  of  6.5%.5 Of  the  418  reported
eaths,  82%  were  stillbirths  and  89%  of  the  mothers  had
ntreated  or  inadequately  treated  syphilis.  Moreover,  less
renatal  care  was  associated  with  increased  risk  of  death,
nd  importantly,  59%  of  the  deaths  occurred  by  31  weeks  of
estation.
It  is  clear  that  pregnant  women  must  have  access  to  early
renatal  care  and  be  screened  serologically  for  syphilis  at
he  ﬁrst  prenatal  visit  and,  in  high  risk  areas,  again  at  28--32
eeks’  gestation  and  delivery.6 According  to  PAHO,  94%  of
regnant  women  in  the  Americas  attended  at  least  one  ante-
atal  care  visit  during  the  pregnancy,  and  80%  received
yphilis  testing  at  some  point  during  the  pregnancy.2 In
razil,  Domingues  et  al.7 interviewed  23,894  women  post-
artum  and  reported  that  98.7%  had  at  least  one  antenatal
are  visit,  89%  had  documentation  of  at  least  one  syphilis
est  on  prenatal  record  cards,  but  only  an  additional  41%  had second  test  performed.  From  2011  to  2014,  PAHO  reported
n  increase  from  81%  to  86%  in  syphilis-infected  women  who
ad  documentation  of  appropriate  treatment,  although  it
as  still  below  its  goal  of  95%.2 It  therefore  is  not  surprising
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hat  congenital  syphilis  remains  a  major  problem  in  Brazil
nd  the  rest  of  the  Americas.
In  addition  to  identiﬁcation  of  infected  pregnant  women,
imely  treatment  is  mandatory  for  prevention  of  congen-
tal  syphilis.8,9 In  locales  where  follow-up  is  uncertain  or
ifﬁcult,  rapid  point-of-care  syphilis  testing  should  be  per-
ormed  so  that  women  are  treated  on  site  and  without  delay.
n  addition,  serologic  testing  and  presumptive  treatment  of
heir  sexual  partner  is  essential  to  prevent  reinfection  and
ransmission  to  the  fetus.10 In  Brazil,  it  has  been  estimated
hat  only  about  12%  of  sexual  partners  received  treatment
or  syphilis,11 certainly  a  failure  of  the  public  health  infra-
tructure  as  contact  tracing  and  treatment  is  the  major
ethod  of  controlling  syphilis  transmission  in  communities.
Penicillin  G  is  the  only  known  effective  antimicrobial
gent  for  preventing  vertical  transmission  of  syphilis  and
reating  fetal  infection.6 Pregnant  women  should  receive  the
enicillin  regimen  appropriate  for  the  stage  of  infection,  and
f  any  dose  of  therapy  is  missed  for  latent  syphilis,  the  full
ourse  of  therapy  must  be  repeated.  Pregnant  women  who
ave  a  history  of  penicillin  allergy  should  be  desensitized
nd  treated  with  penicillin.
Unfortunately,  the  diagnosis  of  congenital  syphilis
emains  problematic  due  to  the  inability  to  detect  or  culture
reponema  pallidum  in  clinical  specimens,  thus  necessi-
ating  reliance  on  laboratory  tests  that  detect  maternal
ontreponemal  and  treponemal  IgG  antibodies  transferred
ransplacentally  to  the  fetus.  Nonetheless,  the  use  of  IgM
mmunoblotting,  PCR  assays,  and  rabbit  infectivity  testing
RIT,  inoculation  of  infected  patient  ﬂuid  into  rabbit  testes
ith  resultant  syphilitic  infection  of  the  rabbit)  in  research
aboratories  has  allowed  evidence-based  rationale  for  the
anagement  of  infants  born  to  mothers  with  reactive  sero-
ogic  tests  for  syphilis.12--15
Neonates  with  proven  or  highly  probably  syphilis,  that
s,  those  who  have  an  abnormal  physical  examination,
erum  quantitative  nontreponemal  serologic  titer  that
s  fourfold  or  higher  than  the  mother’s  titer,  or  pos-
tive  darkﬁeld  microscopy  or  PCR  of  lesions  or  body
uids/tissues/placenta,16 are  diagnosed  readily  and  should
eceive  10  days  of  intravenous  aqueous  crystalline  penicillin
 or  intramuscular  procaine  penicillin  G  therapy.  Virtually  all
f  these  infants  have  a  positive  IgM  immunoblot,  and  at  least
0%  of  them  have  spirochetes  detected  in  cerebrospinal  ﬂuid
y  RIT.17
The  well-appearing  infant  with  a  normal  physical  exami-
ation  and  born  to  a  mother  with  untreated  or  inadequately
reated  (<4  weeks  before  delivery  or  any  nonpenicillin  G
egimen)  syphilis  remains  a  diagnostic  conundrum.  However,
hile  as  many  as  20%  of  these  infants  have  a  positive  IgM
mmunoblot  indicative  of  in  utero  infection,  almost  none
ill  have  central  nervous  system  invasion  by  T.  pallidum  if
heir  complete  evaluation  (complete  blood  cell  count  and
latelets,  long  bone  radiographs,  and  cerebrospinal  ﬂuid
CSF]  examination)  is  normal.17 These  infants  can  receive
 single  intramuscular  injection  of  benzathine  penicillin
 (50,000U/kg).6 Finally,  normal  infants  born  to  mothers
dequately  treated  during  pregnancy  and  greater  than  4
eeks  before  delivery  should  be  considered  as  a  ‘‘close
ontact’’  and  receive  a  single  intramuscular  injection  of
enzathine  penicillin  G,  although  no  evaluation  is  required
r  recommended.6 Similarly,  normal  infants  who  have
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 nonreactive  serum  nontreponemal  test  result  but  are
orn  to  mothers  with  untreated  or  inadequately  syphilis
an  receive  a  single  dose  of  intramuscular  benzathine
enicillin  G  without  evaluation  --  an  increasingly  common
cenario  with  the  use  of  treponemal  tests  such  as  enzyme
mmunoassays  or  chemiluminescence  immunoassays  for
yphilis  screening  (‘‘reverse  sequence’’  screening).18
As  syphilis  can  be  a  co-factor  for  HIV  infection,  all  women
nd  their  sexual  partner(s)  who  have  syphilis  should  be
ested  for  HIV  infection.  Infants  born  to  mothers  coinfected
ith  syphilis  and  HIV  do  not  require  different  evaluation,
herapy  or  follow-up.
All  infants  with  reactive  nontreponemal  tests  should
eceive  careful  follow-up  examinations  and  serologic  test-
ng  (i.e.,  a  nontreponemal  test)  every  2--3  months  until
he  test  becomes  nonreactive.  A  reactive  serum  trepone-
al  test  beyond  18  months  of  age  when  maternal  antibodies
ave  disappeared  conﬁrms  a  diagnosis  of  congenital  syphilis,
lthough  as  many  as  20%  of  infected  infants  may  serorevert
ompletely  to  nonreactive  syphilis  serologic  tests.
Recently,  a  penicillin  shortage  in  Brazil  and  other  parts
f  the  world  has  posed  a  serious  health  threat  to  fetuses
nd  infants  of  mothers  with  syphilis.  If  preparations  of  peni-
illin  are  unavailable,  a  10  day  course  of  ceftriaxone  can
e  considered  with  careful  clinical  and  serologic  follow-
p,  including  repeat  CSF  evaluation.6,19 Research  efforts  are
eeded  to  evaluate  whether  other  antibiotics  such  as  ampi-
illin  can  treat  effectively  central  nervous  system  disease.
The  lack  of  timely  identiﬁcation  and  appropriate  treat-
ent  of  infected  infants  can  have  profound  consequences  in
ater  life.  Manifestations  of  late  congenital  syphilis  involve
he  central  nervous  system,  bones  and  joints,  teeth,  eyes,
nd  skin  and  include  Hutchinson’s  triad  (interstitial  kerati-
is,  eighth  cranial  nerve  deafness,  notched  central  incisors),
amed  after  Sir  Jonathan  Hutchinson  (1828--1913)  from
ngland.
Research  and  humanitarian  efforts  must  continue  to  con-
rol,  treat,  and  eventually  eliminate  congenital  syphilis
lobally.  The  public  health  impact  of  syphilis  in  pregnancy
nd  infancy  remains  substantial,  and  only  through  optimal
renatal  healthcare  services  will  elimination  of  maternal-
o-child  transmission  of  syphilis  become  a reality  in  the
mericas.
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